Physician

Adam D Standiford, PA-C

According to 2025 Medicare claims, Adam Standiford, PA-C (NPI: 1932731999) practices physician assistant in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is PARAGON HEALTH, P.C. (NPI: 1902847098; TIN: 383309299) and primary practice location at 49024-4883.

Standiford's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 726 traditional Medicare patients, billed 3,058 HCPCS/CPT codes, and received $84,364 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,545 prescription claims across 706 beneficiaries totaling $1,177,703 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 99 records totaling $2,213. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,889 to $1,177,703. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$48K$96K2020 Medicare payment: $51,590 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $68,444 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $96,181 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $89,738 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $84,364 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020104737$51,590
20213771,808$68,444
20226422,747$96,181
20237003,224$89,738
20247263,058$84,364

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$589K$1.2M2020 Drug cost: $5,889 (USD; Tot_Drug_Cst)2021 Drug cost: $93,497 (USD; Tot_Drug_Cst)2022 Drug cost: $395,323 (USD; Tot_Drug_Cst)2023 Drug cost: $1,103,279 (USD; Tot_Drug_Cst)2024 Drug cost: $1,177,703 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20205171$5,889
2021288628$93,497
2022470934$395,323
20236021,322$1,103,279
20247061,545$1,177,703

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths175189$60
11102Biopsy of related skin growth, first growth163175$49
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more535646$45
17000Destruction of precancer skin growth, 1 growth323371$28
17003Destruction of precancer skin growth, 2-14 growths2331,107$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab441,182$171,187
Enbrel SureclickEtanercept12336$101,936
Taltz AutoinjectorIxekizumab14392$95,266
Dupixent SyringeDupilumab25672$94,156
OtezlaApremilast12358$57,235

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.99$2,213E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam D. Standiford, PA-C?

Tedicare shows public-source Medicare data for Adam D. Standiford, PA-C (NPI 1932731999), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam D. Standiford, PA-C have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam D. Standiford, PA-C?

Adam D. Standiford, PA-C is linked to PARAGON HEALTH, P.C. (billing NPI 1902847098) in the available physician profile data.

Does Adam D. Standiford, PA-C have Open Payments data?

Adam D. Standiford, PA-C has 99 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.